MedTrace Logo

Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

NCT01980862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2014-08-05

No results posted yet for this study

Summary

Single-site blood collection investigation.

Conditions

  • To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms

Sponsors & Collaborators

  • Fujirebio Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Christenson, MD · Universtiy of Maryland School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01980862 on ClinicalTrials.gov